Gene Signal Enters Phase III Clinical Tests for the Prevention of Corneal Graft Rejection
LAUSANNE, Switzerland, November 10 /PRNewswire/ --
- Gene Signal International, a Biotech Company Registered in Switzerland, Will Move its Headquarters to the EPFL, in Lausanne, - Gene Signal is…